Prenyl-IN-1 |
| Katalog-Nr.GC31276 |
Prenyl-IN-1 ist ein Protein-Prenylierungsinhibitor, insbesondere ein Geranylgeranyltransferase (GGT)- oder ein Farnesyltransferase (FT)-Inhibitor, der eine starke AktivitÄt gegen oxidativen Stress und insbesondere bei der Behandlung der Parkinson-Krankheit zeigt.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 360561-53-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Prenyl-IN-1 is a protein prenylation inhibitor, especially a geranylgeranyltransferase (GGT) or a farnesyltransferase (FT) inhibitor, exhibiting potent activity against oxidative stress, and particularly in the treatment of Parkinson's Disease.
[1]. Compounds which inhibits protein prenylation e.g. geranylgeranyltransferase or farnesyltransferase inhibitors for treating parkinson's disease. WO2006051423A1
Average Rating: 5 (Based on Reviews and 31 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *